# Nuclide record i131-mibg (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/i131-mibg/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "i131-mibg" ;
  schema:name "131I-MIBG (iobenguane I-131) therapy"@en ;
  schema:description "High-dose radioactive MIBG delivers radiation from inside neuroblastoma cells that take up noradrenaline; used for relapsed disease and tested in upfront therapy."@en ;
  schema:url <https://nuclide.cc/drugs/i131-mibg/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Iobenguane> ;
  owl:sameAs <http://www.wikidata.org/entity/Q27286979> ;
  schema:citation <https://en.wikipedia.org/wiki/Iobenguane> ;
  nuclide:status "established" ;
  nuclide:modality "Radioligand therapy (beta, norepinephrine transporter)" ;
  nuclide:related <https://nuclide.cc/isotopes/i-131/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroblastoma/>, <https://nuclide.cc/indications/neuroblastoma-high-risk/>, <https://nuclide.cc/indications/metastatic-ppgl/> ;
  nuclide:technologies <https://nuclide.cc/technologies/mibg-theranostics/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:companies <https://nuclide.cc/companies/lantheus/> ;
  nuclide:trials <https://nuclide.cc/trials/anbl1531/> .